Abstract
HIV causes a chronic infection characterized by depletion of CD4+ T lymphocytes and the development of opportunistic infections. Despite drugs that inhibit viral spread, HIV infection has been difficult to cure because of uncharacterized reservoirs of infected cells that are resistant to highly active antiretroviral therapy (HAART) and the immune response. Here we used CD34+ cells from infected people as well as in vitro studies of wild-type HIV to show infection and killing of CD34+ multipotent hematopoietic progenitor cells (HPCs). In some HPCs, we detected latent infection that stably persisted in cell culture until viral gene expression was activated by differentiation factors. A unique reporter HIV that directly detects latently infected cells in vitro confirmed the presence of distinct populations of active and latently infected HPCs. These findings have major implications for understanding HIV bone marrow pathology and the mechanisms by which HIV causes persistent infection.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bukrinsky, M.I., Stanwick, T.L., Dempsey, M.P. & Stevenson, M. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 254, 423–427 (1991).
Bailey, J.R. et al. Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells. J. Virol. 80, 6441–6457 (2006).
Neal, T.F. et al. CD34+ progenitor cells from asymptomatic patients are not a major reservoir for human immunodeficiency virus-1. Blood 86, 1749–1756 (1995).
Weichold, F.F. et al. Neither human immunodeficiency virus-1 (HIV-1) nor HIV-2 infects most-primitive human hematopoietic stem cells as assessed in long-term bone marrow cultures. Blood 91, 907–915 (1998).
Majka, M. et al. Bone marrow CD34+ cells and megakaryoblasts secrete β-chemokines that block infection of hematopoietic cells by M-tropic R5 HIV. J. Clin. Invest. 104, 1739–1749 (1999).
Zhang, J., Scadden, D.T. & Crumpacker, C.S. Primitive hematopoietic cells resist HIV-1 infection via p21. J. Clin. Invest. 117, 473–481 (2007).
Zhang, C.C., Kaba, M., Iizuka, S., Huynh, H. & Lodish, H.F. Angiopoietin-like 5 and IGFBP2 stimulate ex vivo expansion of human cord blood hematopoietic stem cells as assayed by NOD/SCID transplantation. Blood 111, 3415–3423 (2008).
Collman, R. et al. An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. J. Virol. 66, 7517–7521 (1992).
Schwartz, O., Marechal, V., Le Gall, S., Lemonnier, F. & Heard, J.M. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat. Med. 2, 338–342 (1996).
Collins, K.L., Chen, B.K., Kalams, S.A., Walker, B.D. & Baltimore, D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391, 397–401 (1998).
Caux, C., Dezutter-Dambuyant, C., Schmitt, D. & Banchereau, J. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature 360, 258–261 (1992).
Chen, B.K., Gandhi, R.T. & Baltimore, D. CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env and nef. J. Virol. 70, 6044–6053 (1996).
Gasmi, M. et al. Requirements for efficient production and transduction of human immunodeficiency virus type 1–based vectors. J. Virol. 73, 1828–1834 (1999).
Yam, P.Y. et al. Design of HIV vectors for efficient gene delivery into human hematopoietic cells. Mol. Ther. 5, 479–484 (2002).
Yamamoto, N. et al. Analysis of human immunodeficiency virus type 1 integration by using a specific, sensitive and quantitative assay based on real-time polymerase chain reaction. Virus Genes 32, 105–113 (2006).
Zufferey, R. et al. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol. 72, 9873–9880 (1998).
Davis, T.A. et al. Phorbol esters induce differentiation of human CD34+ hemopoietic progenitors to dendritic cells: evidence for protein kinase C–mediated signaling. J. Immunol. 160, 3689–3697 (1998).
Kuroda, H., Kutner, R.H., Bazan, N.G. & Reiser, J. Simplified lentivirus vector production in protein-free media using polyethylenimine-mediated transfection. J. Virol. Methods 157, 113–121 (2008).
Kohno, T. et al. A new improved method for the concentration of HIV-1 infective particles. J. Virol. Methods 106, 167–173 (2002).
Yamamoto, N. et al. Analysis of human immunodeficiency virus type 1 integration by using a specific, sensitive and quantitative assay based on real-time polymerase chain reaction. Virus Genes 32, 105–113 (2006).
Clouse, K.A. et al. Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. J. Immunol. 142, 431–438 (1989).
Acknowledgements
This work was funded by US National Institutes of Health grant RO1 AI051192, MO1-RR000042, the Burroughs Wellcome Foundation, the University of Michigan Molecular Mechanisms in Microbial Pathogenesis Training Grant (C.C.C.), the Rackham Predoctoral Fellowship (C.C.C.), a US National Science Foundation predoctoral fellowship (L.A.M.) and a Bernard Maas Fellowship (L.A.M.). We thank C. van de Ven (University of Michigan) for umbilical cord blood and C. McIntyre-Ramm for assistance with human studies. The following reagents were obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, US National Institutes of Health: p89.6 from R.G. Collman (University of Pennsylvania), pNL4-3 from M. Martin (Viral Pathogenesis and Vaccine Section at the US National Institute of Allergy and Infectious Diseases), p94UG–114.1 and pYU-2 from B. Hahn (University of Alabama at Birmingham) and pMJ4 from T. Ndung'u (Nelson Mandela School of Medicine), B. Renjifo (Harvard School of Public Health) and M. Essex (Harvard School of Public Health). pCMV-G was from N. Hopkins, (Massachusetts Institute of Technology), pCMV-HIV-1 and pHIV-7/SF-GFP were from S.-J.-K. Yee (City of Hope National Medical Center) and pEGFP-N2-LAMP1 was from N. Andrews (Yale University).
Author information
Authors and Affiliations
Contributions
C.C.C., L.A.M. and A.O.-N. conducted in vitro experiments and data analysis and assisted with writing the manuscript. J.R. IV assisted with human subjects. M.R.S. and D.B. obtained bone marrow aspirates and assisted with human subjects. K.L.C. supervised the project and wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–7 and Supplementary Table 1 (PDF 709 kb)
Rights and permissions
About this article
Cite this article
Carter, C., Onafuwa-Nuga, A., McNamara, L. et al. HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs. Nat Med 16, 446–451 (2010). https://doi.org/10.1038/nm.2109
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.2109